NEW YORK, June 27 (Praxis Press) Heparins have been shown to be effective and safe in the treatment of deep vein thrombosis, but the use of this treatment on an outpatient versus an inpatient basis ...
Treatment for thrombophlebitis depends on the severity and location of the condition. Options for thrombophlebitis that affect the deep veins may include surgery and medications that help prevent or ...
Please provide your email address to receive an email when new articles are posted on . Atorvastatin therapy did not reduce risk for venous or arterial thrombosis or all-cause death among patients ...
The first clinical trial to compare two commonly used drugs head-to-head for venous thrombosis treatment has found a clear winner: while both drugs work well to prevent recurrent blood clots, apixaban ...
An international clinical trial led by Dr. Lana Castellucci of The Ottawa Hospital and the University of Ottawa shows that apixaban is safer than rivaroxaban for treating venous thrombosis. The first ...
Blood clotting helps stem the bleeding from a wound, suppressing blood loss and stopping pathogenic microorganisms from entering the body. However, there’s a dark side to blood clotting. A blood clot, ...
Stent thrombosis is a rare, but serious, complication of percutaneous coronary intervention and is associated with severe morbidity and mortality Intravascular imaging has furthered our understanding ...
Deep vein thrombosis (DVT) happens when there’s a blood clot in one or more of the deep veins in your body. Various factors could put you at risk for thrombosis. You may be more likely to have a DVT ...
Please provide your email address to receive an email when new articles are posted on . World Thrombosis Day is observed Oct. 13. The campaign is intended to raise awareness of the condition, ...
Cephalic vein thrombosis is a blood clot in the cephalic vein in the arm. It occurs when something affects the vein’s blood flow to the heart. The condition generally resolves by itself but can become ...
A rare syndrome has been observed in people following vaccination against COVID-19. This involves thrombosis at unusual sites in the body, associated with a low thrombocyte count and a clotting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results